Literature DB >> 8016777

Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.

P P Nunn1, A M Elliott, K P McAdam.   

Abstract

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Developing Countries; Diseases; Examinations And Diagnoses; Hiv Infections; Infections; Literature Review; Treatment; Tuberculosis; Viral Diseases

Mesh：

Substances：

Year:  1994        PMID： 8016777      PMCID： PMC474877          DOI： 10.1136/thx.49.5.511

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  80 in total

1.  Trends in HIV-1 and HIV-2 infection in The Gambia.

Authors:  A Wilkins; B Oelman; J Pepin; K Cham; T Corrah; A Hughes; K Manneh; K Manneh; R Njai; M Rolfe
Journal:  AIDS       Date:  1991-12       Impact factor: 4.177

2.  Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan.

Authors:  A Aziz; S H Siddiqi; K Aziz; M Ishaq
Journal:  Tubercle       Date:  1989-03

Review 3.  The relationship between delayed type hypersensitivity and protective immunity induced by mycobacterial vaccines in man.

Authors:  P E Fine; J M Pönnighaus; N P Maine
Journal:  Lepr Rev       Date:  1986-12       Impact factor: 0.537

4.  High initial drug resistance in pulmonary tuberculosis in Ghana.

Authors:  T S van der Werf; D G Groothuis; B van Klingeren
Journal:  Tubercle       Date:  1989-12

5.  The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis.

Authors:  P Nunn; M Mungai; J Nyamwaya; C Gicheha; R J Brindle; D T Dunn; W Githui; J O Were; K P McAdam
Journal:  Tuber Lung Dis       Date:  1994-02

6.  Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results.

Authors:  W Githui; P Nunn; E Juma; F Karimi; R Brindle; R Kamunyi; S Gathua; C Gicheha; J Morris; M Omwega
Journal:  Tuber Lung Dis       Date:  1992-08

7.  Drug resistance of Mycobacterium tuberculosis in Korea.

Authors:  S J Kim; Y P Hong
Journal:  Tuber Lung Dis       Date:  1992-08

8.  Cytolytic T-cell activity against mycobacterial antigens in HIV.

Authors:  M Forte; G Maartens; M Rahelu; J Pasi; C Ellis; H Gaston; D Kumararatne
Journal:  AIDS       Date:  1992-04       Impact factor: 4.177

9.  Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome.

Authors:  Y L Abouya; A Beaumel; S Lucas; A Dago-Akribi; G Coulibaly; M N'Dhatz; J B Konan; A Yapi; K M De Cock
Journal:  Am Rev Respir Dis       Date:  1992-03

10.  Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.

Authors:  P Nunn; R Brindle; L Carpenter; J Odhiambo; K Wasunna; R Newnham; W Githui; S Gathua; M Omwega; K McAdam
Journal:  Am Rev Respir Dis       Date:  1992-10
View more
  11 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Implementation of the thin layer agar method for diagnosis of smear-negative pulmonary tuberculosis in a setting with a high prevalence of human immunodeficiency virus infection in Homa Bay, Kenya.

Authors:  Anandi Martin; Peter Munga Waweru; Fred Babu Okatch; Naureen Amondi Ouma; Laurence Bonte; Francis Varaine; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

Review 3.  Escalating threat from tuberculosis: the third epidemic.

Authors:  A S Malin; K P McAdam
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 4.  AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

5.  Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis.

Authors:  A Bandera; A Gori; L Catozzi; A Degli Esposti; G Marchetti; C Molteni; G Ferrario; L Codecasa; V Penati; A Matteelli; F Franzetti
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Trends in Hospitalisation for Human Immunodeficiency Virus in a Tertiary Hospital in Dar es Salaam, Tanzania: A Case study.

Authors:  Grace A Shayo; Tumaini Nagu; Lilian Msele; Patricia Munseri; Columba Mbekenga; Steven Kibusi; Kisali Pallangyo; Ferdinand Mugusi
Journal:  East Afr Health Res J       Date:  2020-06-26

7.  Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Authors:  Lydia Nakiyingi; Willy Ssengooba; Damalie Nakanjako; Derek Armstrong; Molly Holshouser; Bruce J Kirenga; Maunank Shah; Harriet Mayanja-Kizza; Moses L Joloba; Jerrold J Ellner; Susan E Dorman; Yukari C Manabe
Journal:  BMC Infect Dis       Date:  2015-02-15       Impact factor: 3.090

8.  Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort.

Authors:  Irene A Biraro; Moses Egesa; Frederic Toulza; Jonathan Levin; Stephen Cose; Moses Joloba; Steven Smith; Hazel M Dockrell; Achilles Katamba; Alison M Elliott
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

9.  Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Authors:  Lydia Nakiyingi; Bareng A S Nonyane; Willy Ssengooba; Bruce J Kirenga; Damalie Nakanjako; Gloria Lubega; Pauline Byakika-Kibwika; Moses L Joloba; Jerry J Ellner; Susan E Dorman; Harriet Mayanja-Kizza; Yukari C Manabe
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.

Authors:  Lydia Nakiyingi; John Mark Bwanika; Bruce Kirenga; Damalie Nakanjako; Catherine Katabira; Gloria Lubega; Joseph Sempa; Barnabas Nyesiga; Heidi Albert; Yukari C Manabe
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.